APA (7th ed.) Citation

Furihata, K., Ishiguro, Y., Yoshimura, N., Ito, H., Katsushima, S., Kaneko, E., . . . Morishige, T. (2021). A Phase 1 Study of KHK4083: A Single‐Blind, Randomized, Placebo‐Controlled Single‐Ascending‐Dose Study in Healthy Adults and an Open‐Label Multiple‐Dose Study in Patients With Ulcerative Colitis. Clinical Pharmacology in Drug Development, 10(8), 870. https://doi.org/10.1002/cpdd.918

Chicago Style (17th ed.) Citation

Furihata, Kenichi, et al. "A Phase 1 Study of KHK4083: A Single‐Blind, Randomized, Placebo‐Controlled Single‐Ascending‐Dose Study in Healthy Adults and an Open‐Label Multiple‐Dose Study in Patients With Ulcerative Colitis." Clinical Pharmacology in Drug Development 10, no. 8 (2021): 870. https://doi.org/10.1002/cpdd.918.

MLA (9th ed.) Citation

Furihata, Kenichi, et al. "A Phase 1 Study of KHK4083: A Single‐Blind, Randomized, Placebo‐Controlled Single‐Ascending‐Dose Study in Healthy Adults and an Open‐Label Multiple‐Dose Study in Patients With Ulcerative Colitis." Clinical Pharmacology in Drug Development, vol. 10, no. 8, 2021, p. 870, https://doi.org/10.1002/cpdd.918.